We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Is Now The Perfect Time To Buy AstraZeneca plc, Imagination Technologies Group plc And BHP Billiton plc?

Should you add these 3 stocks to your portfolio? AstraZeneca plc (LON: AZN), Imagination Technologies Group plc (LON: IMG) and BHP Billiton plc (LON: BLT)

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

All companies have periods where their financial performance is somewhat disappointing. That is just the nature of business and, while it can mean a fall in the company’s share price in the short term, it can also lead to major changes at the company which puts it on a stronger footing for the long term. And, for investors willing to take a risk on such a stock, the rewards can be hugely enticing.

For example, AstraZeneca (LSE: AZN) has endured a torrid time in recent years, with a number of its key, blockbuster drugs losing their patent protection. This has led to falling sales as generic competition grabs market share and, as a result, AstraZeneca’s top line has fallen from just under £22bn in 2011 to a forecast of less than £16bn in the current year. And, while cost cuts and efficiencies have been made, AstraZeneca’s earnings have also tumbled by over 40% during the same time period.

Should you buy AstraZeneca Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

However, AstraZeneca has made major changes to its business so as to position itself for future growth. Notably, it has engaged in considerable M&A activity, which has boosted its pipeline and caused market sentiment to improve as investors begin to factor in potential earnings growth from 2017 onwards. Furthermore, AstraZeneca has shifted its focus towards treatments for conditions such as diabetes that offer huge growth potential in the coming decades, thereby setting the company up for upbeat ultra-long term growth potential.

Despite its share price having risen by 49% since the start of 2013, AstraZeneca still offers excellent value for money. For example, it trades on a price to earnings (P/E) ratio of 15.7 and has a dividend yield of 4.2%; both of which indicate that now is a great time to buy a slice of the pharmaceutical play.

Similarly, BHP Billiton (LSE: BLT) has also endured a challenging period, with the prices of commodities tumbling and causing its earnings to decline by 52% last year. And, in the current year, they are forecast to fall by a further 33% which, in the short run, could hurt investor sentiment.

However, with BHP spinning off non-core assets, cutting costs and generating efficiencies, it appears to be addressing the challenges which it faces. This, in the long run, could leave it in a stronger position relative to its peers and lead to much improved profitability in the coming years. Certainly, a P/E ratio of 20.8 is hardly cheap but, for one of the largest and best diversified mining stocks in the world, it appears to be a price worth paying for sound long term growth prospects.

Meanwhile, Imagination Technologies (LSE: IMG) today announced a profit warning for the first half of the current year. It is blaming a slowdown in the semiconductor sector, with reduced demand from emerging markets being a key cause. As such, it expects to post a loss in the first half of the year. And, while the company expects the second half of the year to be a major improvement, it has stated that it may not fully offset a tough first half of the year.

Due to the profit warning, shares in Imagination Technologies are down by over 10% today. Clearly, this is disappointing for the company’s investors but, realistically, it is most likely to be a weak six-month period rather than the start of a prolonged period of decline. Furthermore, with Imagination Technologies being forecast to increase its earnings at a double-digit rate next year, it remains a very enticing growth stock which, for long term investors, is now trading at an even more appealing share price.

Peter Stephens owns shares of AstraZeneca and BHP Billiton. The Motley Fool UK owns shares of Imagination Technologies. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young black female footballer training on stadium pitch
Investing Articles

How has this FTSE 250 share surged ANOTHER 7% today?

Applied Nutrition shares have soared on Monday after another brilliant trading update. So what's the FTSE 250 company's secret?

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

The stock market game you’re actually playing (and why you might be losing)

Our writer recounts a painful experience of making a rash stock market decision based on emotions, not logic – and…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Why is EasyJet stock suddenly a takeover target for US investors?

Andrew Mackie looks at easyjet shares jumping on US takeover talk — but is this a genuine re-rating or just…

Read more »

Young Black woman looking concerned while in front of her laptop
Investing Articles

Have investors got BT shares all wrong?

BT shares spiked during the 1990s telecom boom, then struggled for two decades. Harvey Jones says it's the future that…

Read more »

BUY AND HOLD spelled in letters on top of a pile of books. Alongside is a piggy bank in glasses. Buy and hold is a popular long term stock and shares strategy.
Investing Articles

Looking for buying opportunities in June? Here’s 1 to consider from my Stocks and Shares ISA

The conflict in Iran is making one of the investments in Stephen Wright’s Stocks and Shares ISA volatile. But could…

Read more »

Row of blue European Union flags in Brussels.
Investing Articles

After crashing 13.7% today, is Wise now a stock market bargain at 805p?

Wise was one of the biggest fallers on the UK stock market today. What on earth is going on with…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

At 8% is this eye-popping FTSE 100 dividend yield simply too good to be true?

The dividend yield is to die for, but the share price is lacking in life. Harvey Jones examines whether this…

Read more »

The flag of the United States of America flying in front of the Capitol building
Investing Articles

UK investors are piling into this legendary S&P 500 growth stock while it’s down 50%

This US growth stock fell from $240 to $80 amid AI disruption fears. And investors are now aggressively buying it…

Read more »